China Meheco Co., Ltd. logo

China Meheco Co., Ltd. (600056)

Market Closed
10 Aug, 06:57
SSE SSE
¥
9. 47
+0.07
+0.7447%
¥
15.86B Market Cap
- P/E Ratio
0.09% Div Yield
20.5M Volume
- Eps
¥ 9.4
Previous Close
Add Transaction
Day Range
9.39 9.58
Year Range
8.3 12.48
Want to track 600056 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600056 closed today higher at ¥9.47, an increase of 0.7447% from yesterday's close, completing a monthly increase of 8.6009% or ¥0.75. Over the past 12 months, 600056 stock lost -8.5907%.
600056 pays dividends to its shareholders, with the most recent payment made on Jun 26, 2026. The next estimated payment will be in In 4 months on Dec 26, 2026 for a total of ¥0.07525.
The last earnings report, released on May 21, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
China Meheco Co., Ltd. has completed 6 stock splits, with the recent split occurring on Jun 24, 2022.
The company's stock is traded on one exchange.

600056 Chart

People also search for

Inner Mongolia Yili Industrial Group Co. Ltd.
¥ 26.41
+0.5712%
Eastroc Beverage Group Co., Ltd.
¥ 126.77
-3.1033%
Tsingtao Brewery Co., Ltd.
¥ 53.62
-0.4456%
Jiangsu King's Luck Brewery Co., Ltd.
¥ 28.37
-0.0704%
Shanghai Pharmaceuticals Holding Co., Ltd.
¥ 16.84
+0.7177%

China Meheco Co., Ltd. (600056) FAQ

What is the stock price today?

The current price is ¥9.47.

On which exchange is it traded?

China Meheco Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600056.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.09%.

What is its market cap?

As of today, the market cap is 15.86B.

Has China Meheco Co., Ltd. ever had a stock split?

China Meheco Co., Ltd. had 6 splits and the recent split was on Jun 24, 2022.

China Meheco Co., Ltd. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Ms. Huidong Hu CEO
SSE Exchange
CNE000000Q29 ISIN
CN Country
8,389 Employees
26 Jun 2026 Last Dividend
19 Jun 2014 Last Split
28 Apr 1997 IPO Date

Overview

China Meheco Group Co., Ltd., established in 1984 and headquartered in Beijing, China, is a prominent player in the pharmaceutical sector, engaging extensively in both domestic and international markets. The company's operations encompass a broad spectrum of activities, including the export and import of natural medicines, pharmaceutical chemicals, medical equipment, and health products. Furthermore, it focuses on the production and distribution of pharmaceutical and health care products along with managing retail chain pharmacies. This diversified approach allows China Meheco Group to cater to a wide range of health-related needs, reinforcing its position in the global pharmaceutical arena.

Products and Services

China Meheco Group Co., Ltd. offers a comprehensive array of products and services designed to meet the diverse needs of the healthcare sector:

  • Bulk pharmaceutical chemicals, antibiotic fermentation, and chemical synthesis - Including tablets, injections, and capsules, these products are essential for treating various conditions.
  • Antibiotics - A critical component in combating bacterial infections and supporting healthcare interventions.
  • Medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes - These tailor-made medications address some of the most prevalent health concerns in modern society.
  • Antiviral - Targeting viruses, these products are key in managing and preventing outbreaks of viral infections.
  • Anti-infectious agents - Integral in controlling and preventing infections, ensuring patient safety and recovery.
  • Gastrointestinal drugs - Designed to treat various digestive tract ailments, offering relief and support to affected individuals.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) - Offering pain relief and inflammation control for numerous conditions.
  • Anti-allergic agents - Essential for managing allergic reactions and improving the quality of life for individuals with allergies.
  • Specialty botanicals - Utilizing the therapeutic properties of plants in treating and managing health conditions.
  • Western medicine preparations - A broad category encompassing various medications prepared according to Western medical principles.
  • Chinese patent medicines and herbal pieces - Traditional Chinese medicine products, offering an alternative approach to health and wellness.
  • Medical equipment and supplies - Providing healthcare providers with the necessary tools for patient care and medical interventions.
  • Biological products - Including vaccines and biological therapies for a variety of diseases and conditions.
  • Chemical raw materials - Essential inputs for the pharmaceutical and healthcare product manufacturing process.
  • Nutritional and healthcare products - Designed to support overall health and well-being, supplementing diets, and providing targeted nutritional support.

In addition to these products, the company is also involved in the cultivation, processing, warehousing, and transportation of a range of herbs, including ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and others. This vertical integration ensures quality control and supply chain stability for its herbal-based products.

Contact Information

Address: No. 18 Guangming Zhongjie, Beijing, China, 100061
Phone: 86 10 6711 6688